Management Team

Dr. Jakub Simecek

Dr. Jakub Simecek

Co-founder & CEO

Jakub´s background in chemistry (Charles University in Prague), radiopharmaceutical sciences (visiting researcher at University of Helsinki and at MSKCC, NY) and development of targeted radiolabelled conjugates, their preclinical evaluation and transfer to first-in-human studies (doctoral degree at TU München) resulted in different positions in radiopharmaceutical industry after leaving the academia. He led various technical (small scale GMP production) and radiopharmaceutical projects toward establishing novel radiodiagnostic and radiotherapeutic applications (innovative Ga-68, Lu-177 and Ac-225 based APIs). Since 2014, he has been active in business with radiopharmaceuticals across the globe. Jakub serves as CEO of TRIMT GmbH and cares also for the business development.

Dirk Freitag-Stechl, MBA

Dr. Dirk Freitag-Stechl, MBA

Co-founder & CFO

Dirk Freitag-Stechl studied chemistry at the Technical University of Dresden. After his dissertation, a research stay at the Polo Scientifico "UGO SCHIFF" in Florence and a position as laboratory manager in the central research department of Henkel AG & Co. KGaA in Düsseldorf, he took over the management of CUP Laboratorien in 2008, which he still leads today as managing partner. Under his leadership, the company developed into one of the leading GMP contract laboratories for radiopharmaceuticals.

Dirk also holds a Master of Business Administration degree and is lecturer for "Strategic Management of SMEs" at the Dresden International University.

Prof. Dr. Johannes Notni

PD Dr. Johannes Notni

Co-founder & CSO

PD Dr. Johannes Notni studied and graduated in chemistry at the University of Jena (Thuringia). After receiving his doctoral degree, he moved to the venerable Charles University in Prague, where he started developing the TRAP technology which now powers innovation at TRIMT GmbH. He continued his academic career at Technical University of Munich for more than a decade, where he developed innovative molecular probes. In 2021, he accepted a position as university professor for experimental radiopharmacy at Universitätsklinikum Essen. In light of the thriving performance of TRIMT, he recently took a full-time position as Chief Science Officer. He now manages and drives the company's technological advancement towards a better diagnosis and cure of the most dreadful cancers.

Dr. Matthias Keck

Dr. Matthias Keck

Head of Sales

Matthias graduated in Molecular Life Science from the University of Erlangen-Nuremberg and subsequently got his PhD for his research in the area of bioinorganic chemistry at the Humboldt-University in Berlin. His first job in industry previously led him to a radiopharmaceutical company to gain valuable experience in the sales environment and set up a first international network in the field of nuclear medicine and radiochemistry. Matthias cares for the global sales of the innovative products of TRIMT.